Advanced search
Start date
Betweenand

Effect of disintegrin-loaded chitosan nanoparticles on malignant glioma cells

Grant number: 13/26805-5
Support Opportunities:Scholarships abroad - Research Internship - Doctorate
Effective date (Start): August 01, 2014
Effective date (End): July 31, 2015
Field of knowledge:Health Sciences - Pharmacy - Pharmaceutical Technology
Principal Investigator:Maria Palmira Daflon Gremião
Grantee:Charlene Priscila Kiill
Supervisor: Florence M. Hofman
Host Institution: Faculdade de Ciências Farmacêuticas (FCFAR). Universidade Estadual Paulista (UNESP). Campus de Araraquara. Araraquara , SP, Brazil
Research place: University of Southern California (USC), United States  
Associated to the scholarship:12/10174-3 - EVALUATION OF CHITOSAN NANOPARTICLES FOR DELIVERY OF POTENTIALLY ACTIVE INTEGRINS INHIBITORS IN GLIOBLASTOMAS, BP.DR

Abstract

Glioblastoma multiforme (GBM), the most malignant and invasive glioma, accounts for 15% of all brain tumors. The current treatment for GBM involves surgery, radiation and temozolomide chemotherapy. Moreover, recurrent tumors are chemoresistant. Therefore there is a critical need for new and effective therapies for GBM. Recently,investigations have shown that the snake venom disintegrin specifically binds to certain integrins on the surface of glioma cells and thereby inhibits their interaction with the extracellular matrix (ECM), resulting in blockage of cell motility and invasiveness. The targeted therapy with the disintegrin is a promising strategy to block integrins signaling pathway. Despite the beneficial effect of disintegrins, the delivery of protein to brain tumors remains a major problem, mainly due to difficulty penetrating the blood brain barrier. To overcome these problems, we will develop a drug delivery systems which will promote the passage of disintegrin into the brain, thereby blocking integrin signaling pathways resulting in a blockage of cell motility and invasiveness of the glioblastoma. During the research stage at University of Southern California, Los Angeles, under the supervision of the Professor Dr. Florence Hofman, disintegrin-loaded chitosan nanoparticles will be evaluated in vitro using different GBM cell lines, and in vivo in the intracranial GBM xenograft model. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Please report errors in scientific publications list using this form.